Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04768036 · ClinicalTrials.gov registry record · NA
A Universal Electronic Health Record-based IMPROVE DD VTE Risk Assessment Model for the Prevention of Thromboembolism in Hospitalized Medically Ill Patients
A NA study, sponsored by Northwell Health.
- Completed
- Registry status
- NA
- Development phase
- 10,699
- Enrollment target
NCT04768036 is a NA study that has completed, run by Northwell Health. The registered enrollment target is 10,699 participants.
The verdict
NCT04768036, a NA study, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 10,699 participants
- Enrollment target
Study Summary
This study will be a multicenter clustered randomized trial of patients in hospitals in which a universal "SMART on FHIR" platform-based EHR-embedded IMPROVE DD VTE clinical prediction rules (CPRs) with electronic order entry has been incorporated into required admission and discharge EHR workflow versus hospitals following UMC for VTE risk assessment of medically ill patients. The patient population will consist of hospitalized, medically ill (non-surgical, non-obstetrical) individuals aged \> 60 years.
Interventions
- OTHER IMPROVE DD VTE Tool
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,699 participants |
| Start Date | 2020-12-21 |
| Est. Completion | 2022-01-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04768036
The ClinicalTrials.gov registry entry for NCT04768036 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10,699 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which IMPROVE DD VTE Tool is the first listed.
NCT04768036 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04768036 about?
NCT04768036 is a clinical study titled "A Universal Electronic Health Record-based IMPROVE DD VTE Risk Assessment Model for the Prevention of Thromboembolism in Hospitalized Medically Ill Patients". This study will be a multicenter clustered randomized trial of patients in hospitals in which a universal "SMART on FHIR" platform-based EHR-embedded IMPROVE DD VTE clinical prediction rules (CPRs) with electronic order entry has been incorporated into required admission and discharge EHR workflow v...
What is the current status of trial NCT04768036?
This trial is currently completed. It is a NA study. The enrollment target is 10,699 participants. The study started on 2020-12-21. Estimated completion is 2022-01-21.
What interventions are being tested in trial NCT04768036?
The interventions under investigation include: IMPROVE DD VTE Tool (OTHER).
Who is sponsoring clinical trial NCT04768036?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.